For millions of families with type 1 diabetes, the struggle to regulate blood sugar, inject insulin, and the anxiety of the disease are always present. There are parents who continuously have to watch their children stabbing their fingers and going through this tiresome procedure multiple times a day. There are also young adults who have to juggle their careers and the management of the disease, which is always present the list of impacts both mental and physical goes on and on. A new research gives the first rays of hope. It is from the Medical University of South Carolina (MUSC) that two scientists have come up with a method of creating stem cells that have been able to reverse type 1 diabetes in mice that had been newly diagnosed. This might be the beginning of a new era when treatments would reach the root cause of the disease instead of simply managing the symptoms.
The discovery is focused on mesenchymal stromal cells (MSCs). It is known that these cells have the capability of modulating immune responses and suppressing inflammation. When it comes to type 1 diabetes, the immune system is confused and attacks the beta cells in the pancreas that produce insulin. But, if the destruction of beta cells is limited or caught early, there is a chance that some of them can be rescued. Researchers at MUSC took MSCs and through genetic engineering, made them produce large amounts of alpha-1 antitrypsin (AAT), a protein that is anti-inflammatory as well as capable of cell protection. These modified cells function in two ways: while immune system is prevented from being excessively activated, the remaining beta cells are shielded too. During the mouse trials, diabetic mice were injected with the AAT-MSCs. To the surprise of the researchers, the therapy not only stopped the autoimmune attack but also brought back blood glucose regulation to normal. The mice started secreting insulin naturally, so to speak, the disease was reversed. Now, the significance of this time point during the disease is huge. In humans, it is during the first few weeks and months after diagnosis that the beta cell mass declines most rapidly and Because of this, the chances of preserving insulin secretion and optimizing glycemic control are greatest. The main investigators stressed that an approach to protect the residual -cell mass during this period could greatly alter the natural history of type 1 diabetes.
In fact, patients do not have to be dependent on insulin for the rest of their lives if this method is implemented. Presently, insulin delivery is the most efficient way to manage the symptoms of diabetes, but it cannot stop the underlying autoimmune reaction. These genetically altered stem cells induce regulatory T cell expansion, which in turn helps in rebuilding immune tolerance This way changing the microenvironment in the pancreas to one that is more permissive to islet survival and function.For a parent like Sarah, whose son is only 10 years old and diagnosed recently, the thought of one day a single treatment could enable their son to play sports without continuous glucose monitoring is almost like a miracle. Her story and others like it are the reason why research in this field means so much on a human level.
Despite promising results, researchers point out this is still work done at the preclinical stage. The article published in Molecular Therapy showed a good effect of the treatment in the mouse model but applying that to people is going to be a whole different ball game – besides the safety part, determining the right dose, and running clinical studies, there is even the factor of individuality and how people respond differently being taken into account. Still, the therapy’s two-pronged approach of modulating the immune system and protecting beta cells makes it a strong contender compared to the early stem cell therapies.
This study is part of a larger series of stem cell breakthroughs for diabetes that include beta cells grown in vitro, and immune system reprogramming. Each step gets us closer to the day when type 1 diabetes is no longer a lifelong disease but one that can be cured. The scenario of disease reversal is a medical breakthrough that could mean new life and hope, not only for the people suffering from this illness, but also for their families children athletes, and professionals.
As the scientific community is encouraged by these mouse model data to take further steps toward clinical application, this MUSC paper But acts as a shining example of medical science’s commitment to turning the dream of a type 1 diabetes cure into a reality.